Invesco Nasdaq Future Gen 200 ETF Rating $32.51 -0.45 (-1.37%) Closing price 09/25/2025 03:59 PM EasternExtended Trading$32.52 +0.01 (+0.02%) As of 09/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Invesco Nasdaq Future Gen 200 ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.QQQS Aggregate RatingModerate Buy 2.70Holdings in QQQS have an aggregate rating of Moderate Buy based on 192 analyst ratings issued in the past year covering 24 companies (20.3% of the portfolio).QQQS Aggregate Price Target$32.51High Prediction$32.51Average Prediction$32.51Low Prediction$32.51Holdings in QQQS have an aggregate price target of $32.51 and a range of $32.51 to $32.51 covering 24 companies (20.3% of the portfolio).QQQS Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Future Gen 200 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 QQQS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.49%SATSEchoStar$73.14+0.1%1.2891 of 5 stars2.43$75.20 2.8%7Analyst Forecast1.36%VSATViasat$28.80+1.1%3.3525 of 5 stars2.38$21.43 -25.6%8Positive News1.30%NKTRNektar Therapeutics$55.62-7.8%4.0389 of 5 stars2.86$91.67 64.8%7Analyst ForecastGap Down1.17%ESPREsperion Therapeutics$2.56+5.3%3.9629 of 5 stars2.80$7.00 173.4%5Gap Down1.06%COMMCommScope$15.69-0.4%4.3685 of 5 stars2.67$14.75 -6.0%9Positive NewsGap Down1.01%ALDXAldeyra Therapeutics$4.95-1.2%2.0528 of 5 stars2.67$9.50 91.9%30.84%ALECAlector$2.93-7.3%3.8881 of 5 stars2.29$4.17 42.2%7Positive NewsAnalyst Forecast0.78%ATAIatai Life Sciences$5.17-5.8%3.2105 of 5 stars3.17$11.25 117.6%6Analyst Forecast0.77%LASRnLight$28.04-3.7%2.0118 of 5 stars3.17$27.42 -2.2%60.77%LITELumentum$159.11+4.2%3.5615 of 5 stars2.89$133.36 -16.2%18Gap Down0.76%BELFBBel Fuse$142.72+0.3%3.74 of 5 stars3.17$136.80 -4.1%60.75%SEDGSolarEdge Technologies$37.90+1.1%3.0109 of 5 stars1.63$18.54 -51.1%27Positive News0.74%AQSTAquestive Therapeutics$5.26-3.0%1.9522 of 5 stars3.00$10.29 95.5%90.71%PRTAProthena$9.36+0.4%2.9834 of 5 stars2.33$19.75 111.0%9Positive NewsHigh Trading Volume0.70%IONSIonis Pharmaceuticals$62.97-1.5%3.9446 of 5 stars2.82$72.71 15.5%17Analyst Forecast0.70%ARDXArdelyx$5.96-3.1%4.2556 of 5 stars3.10$11.70 96.3%100.70%GILTGilat Satellite Networks$11.70-0.3%2.4392 of 5 stars3.50$11.00 -6.0%20.69%IHRTiHeartMedia$2.80+3.7%1.126 of 5 stars2.20$2.92 4.2%5Positive News0.68%INVZInnoviz Technologies$1.72-1.7%3.1113 of 5 stars2.50$2.58 49.7%40.68%ARWRArrowhead Pharmaceuticals$31.66-3.6%4.1158 of 5 stars3.00$43.14 36.3%80.68%AMSCAmerican Superconductor$57.96-2.8%1.5436 of 5 stars3.00$34.00 -41.3%2Positive NewsGap Down0.67%IQiQIYI$2.69-0.4%2.1105 of 5 stars2.25$2.51 -6.5%8Positive News0.67%LXRXLexicon Pharmaceuticals$1.34+0.8%2.0842 of 5 stars2.50$3.23 140.7%60.66%KOPNKopin$2.34-7.1%2.0331 of 5 stars3.00$3.00 28.2%3Gap Up This page (NASDAQ:QQQS) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredMagnificent 7 being replaced by the “Secret 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Future Gen 200 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Future Gen 200 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.